Successful completion of USFDA inspection at Alembic Pharma Oral Solid Formulation Facility (F-I) at Panelav Read more
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData Read more
Oral JAK inhibitor LEQSELVI (deuruxolitinib) approved by US FDA for severe alopecia areata treatment Read more
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study Read more
Alembic gains USFDA final approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg Read more
Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution Read more
ZIM Laboratories gains approval to market Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in Portugal Read more